Gemma E. Hartley

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding.

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding.

Journal: NPJ vaccines
Published: October 25, 2023

COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants.

COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants.

Journal: Journal of clinical immunology
Published: March 30, 2023

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Journal: Frontiers in immunology
Published: December 13, 2022

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2.

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2.

Journal: Allergy
Published: August 18, 2022

Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination.

Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination.

Journal: Biochemical Society transactions
Published: July 14, 2022

New insights into human immune memory from SARS-CoV-2 infection and vaccination.

New insights into human immune memory from SARS-CoV-2 infection and vaccination.

Journal: Allergy
Published: June 20, 2022

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Journal: Frontiers in immunology
Published: March 04, 2022

The benefit of boosters: diversity and inclusion in the COVID-19 memory response.

The benefit of boosters: diversity and inclusion in the COVID-19 memory response.

Journal: Immunology and cell biology
Published: November 10, 2021

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.

Journal: Science immunology
Published: November 25, 2020

Influenza-specific IgG1+ memory B-cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency.

Influenza-specific IgG1+ memory B-cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency.

Journal: Clinical & translational immunology
Published: April 07, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026